Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization ![]() |
Active Organization ![]() |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | ![]() | 21 Jun 2024 |
Amyotrophic Lateral Sclerosis | Preclinical | US | ![]() | 21 Jun 2024 |
Hypertension | Preclinical | US | ![]() | 21 Jun 2024 |
Nonalcoholic Steatohepatitis | Preclinical | US | ![]() | 21 Jun 2024 |
Autoimmune Diseases | Preclinical | AR | ![]() | - |
Diabetes Mellitus, Type 2 | Preclinical | AR | ![]() | - |
Metabolic Syndrome | Preclinical | AR | ![]() | - |
Obesity | Preclinical | AR | ![]() | - |